Latest Lead News

Strickland Metals has announced a significant new gold and base metals discovery at its Rogozna Project in Serbia, expanding the potential of its already substantial mineral resources. The discovery at Red Creek lies just 1km from the major Shanac Deposit, promising further growth opportunities.

Ryman Healthcare has unveiled a refreshed strategy focused on growing recurring earnings and optimising its portfolio, targeting a $150 million sustainable cash flow improvement and $500 million cash release by FY29. The company plans to resume dividends from FY28, underpinned by a resilient balance sheet and disciplined capital management.

St George Mining has released a comprehensive investor presentation spotlighting its Araxá Project in Brazil, positioning itself as a major global player in niobium and rare earth elements with significant resource expansion and strategic partnerships underway.

OncoSil Medical Ltd has launched an $8 million equity raising to fund the commercial expansion and clinical development of its targeted radiotherapy device for pancreatic cancer, aiming to capitalise on growing European market adoption and upcoming trial catalysts.

OncoSil Medical Limited has announced a fully underwritten $2 million entitlement offer alongside a $6 million placement to fund its clinical and commercial growth initiatives. The capital raising includes new shares and options, with shareholder approvals pending for certain components.

Grand Gulf Energy has acquired the Dry Wash Antimony Project in Utah, positioning itself alongside active high-grade exploration by American Tungsten and Antimony Limited. The company plans rapid exploration and has raised $500,000 to fund its initial work program.

Little Green Pharma Ltd is set to acquire Cannatrek Ltd in a transformative merger that will create one of the largest vertically integrated medicinal cannabis companies globally, with pro-forma FY25 revenue exceeding AUD 112 million.

Cannindah Resources has raised $15 million through a two-tranche placement and launched a $2 million share purchase plan to fund expanded exploration at its Mt Cannindah Copper-Gold Project.

NRW Holdings has landed three major contracts worth approximately $270 million, reinforcing its footprint in mining and infrastructure projects across Western Australia. These wins highlight NRW’s expanding role in critical regional developments set to unfold over the next two years.

Imricor Medical Systems has welcomed Oklahoma Heart Institute as the fourth U.S. site in its pivotal VISABL-AFL clinical trial, accelerating patient recruitment and the FDA approval pathway for its MRI-guided cardiac ablation technology.

Rhythm Biosciences has secured a multi-year commercial manufacturing agreement with US-based Quansys Biosciences to produce ColoSTAT® reagent kits, paving the way for broader market rollout of its colorectal cancer diagnostic test.

Xero Limited has outlined a bold AI strategy and detailed the integration of Melio to accelerate its US market growth, supported by new financial disclosures and a clear path to profitability.